BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 131 filers reported holding BIOSCRIP INC in Q3 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $3,000 | -80.0% | 295 | -75.5% | 0.00% | – |
| Q1 2013 | $15,000 | +15.4% | 1,206 | 0.0% | 0.00% | – |
| Q4 2012 | $13,000 | +18.2% | 1,206 | 0.0% | 0.00% | – |
| Q3 2012 | $11,000 | +22.2% | 1,206 | -0.1% | 0.00% | – |
| Q2 2012 | $9,000 | +12.5% | 1,207 | 0.0% | 0.00% | – |
| Q1 2012 | $8,000 | +14.3% | 1,207 | 0.0% | 0.00% | – |
| Q4 2011 | $7,000 | -56.2% | 1,207 | -52.4% | 0.00% | -100.0% |
| Q3 2011 | $16,000 | 0.0% | 2,534 | 0.0% | 0.00% | 0.0% |
| Q2 2011 | $16,000 | -20.0% | 2,534 | -42.0% | 0.00% | 0.0% |
| Q1 2011 | $20,000 | -62.3% | 4,367 | -57.0% | 0.00% | -50.0% |
| Q4 2010 | $53,000 | +39.5% | 10,155 | +37.2% | 0.00% | 0.0% |
| Q3 2010 | $38,000 | +1800.0% | 7,400 | +2070.1% | 0.00% | – |
| Q2 2010 | $2,000 | 0.0% | 341 | +28.7% | 0.00% | – |
| Q1 2010 | $2,000 | 0.0% | 265 | 0.0% | 0.00% | – |
| Q4 2009 | $2,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |